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Abstract 
In a normal mature neuron, microtubule associated protein tau promotes the assembly of tubulin into microtubules and maintains the structure 
of microtubules. In Alzheimer disease brain, tau is abnormally hyperphosphorylated and is the major protein subunit of paired helical filaments 
(PHF). In the present study, the biological activity of tau in PHF and the effect of dephosphorylation on this activity were examined. PHF were 
isolated from Alzheimer disease brains and tau from the untreated or alkaline phosphatase-treated PHF was extracted by ultrasonication in 
microtubule assembly buffer. Tubulin was isolated by phosphocellulose chromatography of three cycled microtubules from bovine brain. PHF-tau 
did not promote assembly of bovine tubulin into microtubules whereas tau from the dephosphorylated PHF produced a robust microtubule assembly. 
These studies suggest (i) that in Alzheimer disease tau in PHF is functionally inactive because of abnormal phosphorylation and (ii) that the abnormally 
phosphorylated site(s) in PHF that inactivates PHF-tau is accessible to enzymatic dephosphorylation i  vitro. 
Key words: Alzheimer disease; Paired helical filament; Microtubule associated protein tau; Protein dephosphorylation; 
Microtubule assembly 
- 
1. Introduction 
Alzheimer disease (AD) is the single largest cause of 
dementia in the elderly. The diagnosis of this neurode- 
generative disease is confirmed by the presence of numer- 
ous neurofibrillary changes of paired helical filaments 
(PHF) in the brain, especially the neocortex [l]. These 
accumulations of PHF occur (a) as neurofibrillary tan- 
gles in neuronal cell bodies, (b) as neuropil threads in the 
dystrophic neurite of the affected neurons in the neu- 
ropil, and (c) as dystrophic and degenerating neurites of 
neuritic (senile) plaques, surrounding a dense core or 
several wisps of extracellular amyloid. Although neurofi- 
brillary tangles of PHF are also seen in a few other 
human neurodegenerative diseases and in small numbers 
in normal aged humans, for reasons presently not 
known, these lesions are not seen in aged animals or in 
any experimentally induced conditions [2]. 
Based on solubility, there are two general populations 
of PHF, PHF-I and PHF-II in AD brain. PHF-I and 
PHF-II are readily and sparingly soluble in sodium do- 
decyl sulfate (SDS), respectively; PHF-II are solubilized 
by ultrasonication and repeated extractions [3]. The 
major protein of PHF is the microtubule-associated pro- 
tein tau [46]. Tau is a family of closely related polypep- 
tides with a molecular weight range of 50,000-68,000 on 
SDS-PAGE [7,8]. The cDNA-derived sequences have re- 
vealed that there are at least six molecular species of 
human tau [9]. All of these tau isoforms are products of 
a single gene and result from differential splicing of the 
mRNA [lO,l 11. Tau is a phosphoprotein. Depending on 
the degree of phosphorylation, tau has different electro- 
phoretic mobilities on SDS-PAGE. Tau in AD brain, 
especially PHF, is abnormally phosphorylated [5,6, 
12,131. The abnormal phosphorylation of tau in PHF 
occurs at several sites [5,6,12]. 
In vitro, tau stimulates microtubule assembly and 
co- assembles with tubulin into microtubules. Tau micro- 
injected into cells increases assembly and decreases the 
rate of disassembly of microtubules in vivo [14]. Previ- 
ously, we did not observe any in vitro assembly of micro- 
tubules from brain cytosol of AD cases and predicted 
abnormal phosphorylation of tau to be a cause of this 
defect [13]. In the present study, we report in vitro 
dephosphorylation of PHF from AD brain and a marked 
increase in the ability of the dephosphorylated PHF-tau 
to promote in vitro assembly of microtubules. 
*Corresponding author. Fax: (1) (718) 494 1080 
Abbreviations: AD, Alzheimer disease; MES, 4-morpholineethane-sul- 
fonic acid; PHF, paired helical filaments; PMSF, phenylmethylsulfonyl 
fluoride; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel elec- 
trophoresis. 
2. Materials and methods 
2.1. Isolation of bovine tub&n and tau 
Bovine brains obtained fresh from a local slaughter house were 
cleaned free of meninges, rinsed in disassembly buffer and cerebral 
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hemispheres processed for in vitro assembly-disassembly cycles to three 
cycled microtubules by the glycerol assembly method of Shelanski et 
al. [I 51. For isolation of tubulin, the final microtubule pellet was ho- 
mogenized using a Dounce homogenizer (20 strokes) in an equal vol- 
ume of 200 mM 4-morpholineethane-sulfonic a id (MES), 0.2 mM 
EDTA, 2 mM EGTA, 2 mM/%mercaptoethanol, 2 mM MgCI,, pH 6.4. 
The homogenate was then left on ice for 30 minutes, centrifuged at 
400,000 x g for 10 min in a Beckman TL-100 Ultracentrifuge to remove 
any non-disassembled microtubule proteins and passed through 
phosphocellulose column as described by Weingarten et al. [16]. Tu- 
bulin, which does not bind to phosphocellulose, was collected and 
concentrated by filtration through Centriprep-30 Concentrator (Ami- 
con, Denver, MA). 
For isolation of tau, the three-cycled microtubule pellet was diluted 
with two volumes of the pH 2.7 buffer (100 mM MES, 0.5 mM MgCI,, 
1 mM EGTA, 0.1 mM EDTA, 0.75 mM NaCI, 2 mM dithiothreitol, 
and 0.1 mM phenylmethylsulphonyl fluoride (PMSF), pH 2.7) and heat 
treated as described bv Grundke-Iqbal et al. 141. Tau, which stays in the 
heat stable fraction, -was then concentrateh~by ultrafiltration using 
Centricon- Concentrator from Amicon (Denver, MA). 
2.2. Isolation of PHF 
PHF were isolated from histopathologically confirmed cases of AD 
obtained within six hours postmortem and stored frozen at -75°C. 
Cerebral cortex, cleaned free of meninges and underlying white matter, 
was processed for the isolation of PHF by the long method of Iqbal et 
al. [3]. PHF isolated by this method, that involves treatment with 2% 
SDS at room temperature, are PHF-II type. Because of the SDS treat- 
ment, the isolated PHF are free from any soluble proteins. 
2.3. Dephosphorylation and extraction of PHFpolypeptides 
PHF were suspended (2 mg protein/ml) in an extraction buffer, pH 
6.4, containing 100 mM MES, 0.1 mM EDTA, 1 mM EGTA, I mM 
MgCl,, 2 mM p-mercaptoethanol, 75 mM NaCl, 0.1 mM GTP, 
25 &ml each of leupeptin, pepstatin and antipain and I mM PMSF. 
One half of the suspension was dephosphorylated by incubating it with 
alkaline phosphatase (Bovine intestinal mucosa, Type VII-S from 
Sigma, St. Louis, MO) (0.2 mg/ml) for 3 h at room temperature. At the 
end of the incubation, the phosphatase was removed from PHF by 
centrifugation at 9,500 x g for 30 min in a Sorvall RC-5B superspeed 
centrifuge using rotor HS-4. The pellet was washed 3 times each with 
250 mM sodium potassium phosphate buffer, pH 7.0, and the extrac- 
tion buffer (see above). The final pellet was then suspended in the 
extraction buffer (1 ml buffer per 1 mg of starting PHF protein) and 
ultrasonicated for 30 min using 8 s on and 4 s off cycles at 50% pulse 
and input 2 with a Branson Ultrasonifier equipped with a microprobe. 
Following ultrasonication, the suspension was centrifuged at 
400,000 x g for 10 min in a Beckman TL-100 ultracentrifuge to remove 
any bundles and intact PHF. The pellet was re-extracted four more 
times as above at the end of which practically no residue was left. All 
five supernatants were pooled and concentrated using Centricon- 
Concentrator, (Amicon, Denver, MA) and used as a source of 
dephosphorylated PHF tau. One half of each PHF preparation was 
treated identically to the dephosphorylated PHF tau except he alkaline 
phosphatase treatment which was omitted. 
Dephosphorylation of PHF was confirmed by Western blots devel- 
oped with monoclonal antibody Tau-I as described previously [12]; 
Tau-l labels PHF-tau only when it is dephosphorylated at abnormal 
phosphorylation sites Ser’%erzU2. 
2.4. Dephosphorylation C$ tau 
Aliquots of bovine tau were treated for dephosphorylation with 
alkaline phosphatase as described above for PHF. Followine the nhos- 
phatase treatment, the tau-phosphatase mixture was heat-treatkd at 
95°C for 5 min to inhibit and remove phosphatase from tau. 
2.5. In vitro assembly of microtubules 
Microtubule assembly was carried out by incubating at 37°C in 1 cm 
quartz microcuvettes bovine tubulin (4 mg/ml) with various 
dephosphorylated or non-dephosphorvlated tau and PHF nreoarations 
(O.-l-O.2 mg/ml) in an assembly buffer-consisting of 100 m-M MES, 0.1 
mM EDTA. I mM EGTA. 1 mM M&l, and I mM B-mercantoethanol. 
pH 6.4, and I mM GTP. The rate if the assembly’reactionrwas moni- 
tored by recording turbidimetric changes at 350 nm in a spectro- 
photometer. Each assembly reaction was followed for up to 20 min. At 
the end of the turbidimetric measurements an aliquot of the incubation 
mixture was examined by negative staining with 2% phosphotungstic 
acid, pH 7.2, on carbon coated grids used for electron microscopy. Two 
to three grids were prepared from each assembly reaction and examined 
with a Philips EM 300 electron microscope as described earlier [17]. 
2.6. Protein assays and Western blots 
Protein concentrations were determined by a modification of the 
method of Lowry [18]. SDS-PAGE and Western blots were carried out 
as described previously [19]. 
3. Results 
PHF isolated by the long procedure of Iqbal et al. [3] 
resulted in a highly purified PHF preparation. Morpho- 
logical characterization of the isolated PHF was re- 
ported previously [3]. The contaminants in this PHF 
fraction were small amounts of lipofuscin, membranes 
and a few fragments of capillaries. A yield of 5-10 ,ug 
protein/g AD neocortex was obtained. 
Treatment of isolated PHF with alkaline phosphatase 
dephosphorylated PHF-tau at Ser’99/Se?02 as deter- 
mined by Western blots of the phosphatase-treated and 
untreated PHF with antibody Tau-1 (Fig. 1). Dephos- 
phorylation of PHF did not dissociate the tangles appar- 
ently, and at the end of the dephosphorylation reaction 
the tangles of PHF could be sedimented at 9,500 x g, 
enabling removal of the phosphatase from the PHF. 
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Fig. I. Western blot of PHF, untreated (lane I) or dephosphorylated 
(lane 2) with alkaline phosphatase. Each gel lane contained 10 fig 
protein. The blot was prepared and developed with the monoclonal 
antibody Tau-1 as described in section 2. The antibody Tau-1 recog- 
nizes PHF-tau only when it is dephosphorylated at Ser’99/Serz02. A 
smear of tau immunoreactivity, typical of PHF, can be seen in lane 2. 
The positions of the molecular weight markers in kilodalton are indi- 
cated on the left margin of lane 1. 
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Fig. 2. Electron micrographs of ultrasonicated PHF preparation alone, untreated with alkaline phosphatase (panel a); the PHF preparation plus 
bovine tubulin, showing no assembly of microtubules (panel b); and dephosphorylated PHF preparation plus bovine tubulin showing assembly of 
microtubules. Not shown in this figure, no microtubules were detected in the tubulin alone assembly control. The negative staining was carried out 
using phosphotungstic acid as described in section 2. 
Ultrasonication of the PHF preparation resulted in the 
dissociation of PHF from the tangles and fragmentation 
of the fibrils. Negative stain electron microscopy of the 
ultrasonicated preparation revealed that most of the 
PHF were fragmented to a single twist length, i.e. into 
80 nm pieces (Fig. 2a). 
Incubation of the ultrasonicated PHF preparation 
with bovine tubulin in the assembly buffer generated 
increase in turbidity at 37°C over tubulin control (Fig. 
3a). However, on electron microscopy of the incubation 
mixture at the end of the assembly reaction, no microtu- 
bules were detected (Fig. 2b). In contrast, the incubation 
mixture in which alkaline phosphatase dephosphor- 
ylated PHF preparation was employed, both an addi- 
tional increase in rate and net turbidity at 350 nm (Fig. 
3a) and as well as a large number of microtubules by 
negative stain electron microscopy were observed (Fig. 
2~). Unlike PHF, the bovine tau treated with alkaline 
phosphatase did not result in any increase but a small 
decrease in the rate and the amount of assembly as deter- 
mined by turbidity assay (Fig. 3b). 
4. Discussion 
The exact relationship between neurofibrillary degen- 
eration and p amyloidosis, the two histopathological 
hallmarks of AD is presently not understood. However, 
increasing evidence suggests that the neurofibrillary de- 
generation is required for the clinical expression of the 
disease, and that the /I amyloidosis alone does not pro- 
duce the disease clinically [20,21]. Understanding of the 
mechanism of neurofibrillary degeneration is therefore 
critical to developing a rational treatment for AD. 
Tau is a phosphoprotein, the biological activity of 
which is regulated by its degree of phosphorylation [22]. 
Soluble non-PHF abnormally phosphorylated tau iso- 
lated from AD brain has been previously shown to be 
dephosphorylated by alkaline phosphatase [23] and 
phosphoseryl/phosphothreonyl protein phosphatases -1, 
-2A and -2B [24-261. Dephosphorylation of PHF-tau by 
alkaline phosphatase on Western blots has also been 
observed previously [12]. The present study demon- 
strates that the microtubule associated protein tau in 
neurofibrillary tangles/PHF is functionally inactive, 
however, its biological activity can be restored by enzy- 
matic dephosphorylation. 
The isolation of PHF from AD brain involved treat- 
ment with 2% SDS. The PHF preparation is, therefore, 
unlikely to be contaminated with any soluble tau. Ultra- 
sonication was necessary for the extraction of tau from 
PHF. The stimulation of the microtubule assembly by 
the dephosphorylated PHF was most likely due to the 
extracted tau and not PHF fragments because no micro- 
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Fig. 3. Turbidity changes at 350 nm showing the rate of the assembly 
of microtubules. The in vitro assembly of microtubules was carried out 
by incubating tubulin (tu), 4 mg/ml with or without tau (r), 0.1 mg/ml 
at 37°C in 100 mM MES, 0.1 mM EDTA, 1 mM EGTA, 1 mM MgCl, 
and 1 mM /&mercaptoethanol, pH 6.4 and 1 mM GTP as described in 
section 2. Turbidity changes using PHF-tau and bovine tau are shown 
in panel a and panel b, respectively. Although PHF-tau (untreated with 
alkaline phosphatase) plus tubulin produced turbidity (panel a, curve 
B) greater than tubulin alone (panel a, curve A), negative stain electron 
microscopy failed to reveal any assembly of microtubules (see Fig. 2, 
panel b). 
tubules were seen growing directly from the latter. The 
cause of the increase in turbidity but no assembly of 
microtubules obtained using non-dephosphorylated 
PHF, at present, is not clear. The turbidity increase 
might be due to self-aggregation of PHF-tau. 
Unlike PHF, treatment of bovine tau with alkaline 
phosphatase did not increase its microtubule assembly- 
promoting activity. A small loss in the activity of the 
phosphatase-treated tau might be due to an over 
dephosphorylation because a certain degree of phospho- 
rylation might be required for the maximal activity of tau 
[27]. Alternatively, some of the tau might be degraded by 
proteases in the alkaline phosphatase preparation not 
completely inhibited by the protease inhibitors used in 
the dephosphorylation incubation mixture. 
Tau is known to be required for the maintenance of 
the microtubule network and thereby the axoplasmic 
transport in neurons. Restoration of the biological activ- 
ity of the inactive tau would be expected to prevent neu- 
rodegeneration. Recent studies have shown the presence 
of a significant pool of soluble abnormally phosphor- 
ylated tau in non-PHF form in AD brain, suggesting that 
tau is most likely phosphorylated prior to its polymeriza- 
tion into PHF [23]. It would thus appear that dephos- 
phorylation of the abnormal tau might prevent both the 
neurofibrillary degeneration and the formation of the 
PHF and the neurofibrillary tangles. In situ the benefici- 
ary effect of the dephosphorylation will be restricted 
mostly to the unpolymerized (non-PHF) pool of the ab- 
normal tau. Tau in PHF is in a beta pleated sheet confor- 
mation, and is thus likely to be depolymerized at a very 
slow rate, if any, and made available for reutilization in 
the affected neurons. Future studies will reveal the effect 
of dephosphorylation on the dissociation of PHF. 
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